Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seiji Yano

Showing results (71-80 of 286) with videos related to

Pageof 29
Sort By:
Anticancer Research|July 28, 2004
A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute studyYoshinori Nio, Makoto Koike, Hiroshi Omori, et al.
Oncology Research|February 24, 2006
CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID miceRui Zheng, Seiji Yano, Helong Zhang, et al.
Anticancer Research|June 3, 2006
Immunohistochemical expression of HER-1 and HER-2 in extrahepatic biliary carcinomaYasumasa Ogo, Yoshinori Nio, Seiji Yano, et al.
Prostaglandins & Other Lipid Mediators|April 5, 2026
Elicitation of allergic airway inflammation modulates the cough response via increased prostaglandin I₂ in ovalbumin-sensitized guinea pigsTakafumi Kobayashi, Johsuke Hara, Yoshihiro Takeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancerTadaaki Yamada, Kunio Matsumoto, Wei Wang, et al.
Journal of Clinical Pharmacology|September 21, 2019
Pharmacokinetics of Neoadjuvant Axitinib Influenced the Efficacy in Patients With Advanced Renal Cell CarcinomaYoshiaki Yamamoto, Toru Otori, Ryo Inoue, et al.
Clinical & Experimental Metastasis|April 23, 2003
A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID miceHelong Zhang, Seiji Yano, Toyokazu Miki, et al.
Anticancer Research|April 12, 2003
Implication of HER-2/neu overexpression for the efficacy of oral fluoropyrimidine-based adjuvant chemotherapy in the patients with estrogen receptor negative breast cancer after surgeryYoshinori Nio, Masayuki Itakura, Hiroshi Omori, et al.
Biochemical and Biophysical Research Communications|February 23, 2022
Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancerSuguru Kasai, Naomi Kuwayama, Yoshiharu Motoo, et al.
World Journal of Surgical Oncology|July 25, 2012
A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1Takeshi Nishi, Yasunari Kawabata, Youko Hari, et al.
Pageof 29

Showing results (71-80 of 286) with videos related to

Sort By:
Pageof 29
Anticancer Research|July 28, 2004
A randomized consent design trial of neoadjuvant chemotherapy with tegafur plus uracil (UFT) for gastric cancer--a single institute studyYoshinori Nio, Makoto Koike, Hiroshi Omori, et al.
Oncology Research|February 24, 2006
CD9 overexpression suppressed the liver metastasis and malignant ascites via inhibition of proliferation and motility of small-cell lung cancer cells in NK cell-depleted SCID miceRui Zheng, Seiji Yano, Helong Zhang, et al.
Anticancer Research|June 3, 2006
Immunohistochemical expression of HER-1 and HER-2 in extrahepatic biliary carcinomaYasumasa Ogo, Yoshinori Nio, Seiji Yano, et al.
Prostaglandins & Other Lipid Mediators|April 5, 2026
Elicitation of allergic airway inflammation modulates the cough response via increased prostaglandin I₂ in ovalbumin-sensitized guinea pigsTakafumi Kobayashi, Johsuke Hara, Yoshihiro Takeda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2009
Hepatocyte growth factor reduces susceptibility to an irreversible epidermal growth factor receptor inhibitor in EGFR-T790M mutant lung cancerTadaaki Yamada, Kunio Matsumoto, Wei Wang, et al.
Journal of Clinical Pharmacology|September 21, 2019
Pharmacokinetics of Neoadjuvant Axitinib Influenced the Efficacy in Patients With Advanced Renal Cell CarcinomaYoshiaki Yamamoto, Toru Otori, Ryo Inoue, et al.
Clinical & Experimental Metastasis|April 23, 2003
A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID miceHelong Zhang, Seiji Yano, Toyokazu Miki, et al.
Anticancer Research|April 12, 2003
Implication of HER-2/neu overexpression for the efficacy of oral fluoropyrimidine-based adjuvant chemotherapy in the patients with estrogen receptor negative breast cancer after surgeryYoshinori Nio, Masayuki Itakura, Hiroshi Omori, et al.
Biochemical and Biophysical Research Communications|February 23, 2022
Dual blockade of MET and VEGFR2 signaling pathways as a potential therapeutic maneuver for peritoneal carcinomatosis in scirrhous gastric cancerSuguru Kasai, Naomi Kuwayama, Yoshiharu Motoo, et al.
World Journal of Surgical Oncology|July 25, 2012
A case of pancreatic neuroendocrine tumor in a patient with neurofibromatosis-1Takeshi Nishi, Yasunari Kawabata, Youko Hari, et al.
Pageof 29